Kornitzer Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Kornitzer Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,062,410	Closed	-$25.4M	–	532
2021 Q1	$25.4M	Buy	1,062,410 +994,510	+1,465%	+$18.5M	0.41%	72
2020 Q4	$991K	Sell	67,900 -32,300	-32%	-$428K	0.02%	425
2020 Q3	$1.42M	Hold	100,200	–	–	0.03%	363
2020 Q2	$1.47M	Buy	+100,200	New	+$1.02M	0.03%	360

Kornitzer Capital Management's GNMK Position: Q2 2021 in Review

Kornitzer Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,062,410 shares — an estimated $25.4M sold.

Kornitzer Capital Management first reported a position in GNMK in Q2 2020 and held it in 4 quarters. The position peaked at $25.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Kornitzer Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Kornitzer Capital Management sold 1,062,410 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $25.4M.
Kornitzer Capital Management first reported a position in GenMark Diagnostics, Inc in Q2 2020 and held it in 4 quarters.
Kornitzer Capital Management's GenMark Diagnostics, Inc position peaked at $25.4M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Kornitzer Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.